Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05518357Phase 1Completed
LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia
PrincipalinvestigatorStart date: 2022-06-24
NCT03825718Early Phase 1Completed
A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
B-cell Acute Lymphoblastic Leukemia
PrincipalinvestigatorStart date: 2019-01-17

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

HeiBei YanDa Ludaopei hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Heng Mei, Doctor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
2 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Dario Campana

NUHS Singapore

Related
1 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Li Li, MD

Kunming Hope of Health Hospital

Related
2 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Kevin Curran, MD

Memorial Sloan Kettering Cancer Center

Related
5 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Franco Locatelli, MD, PhD

Director Department of Hematology/Oncology and Cell and Gene Therapy

Related
2 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Abdel-Azim Hisham, MD

Loma Linda University

Related
1 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Nicola Gökbuget, MD

Klinikum der Goethe Universität Frankfurt

Related
2 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

David Shook, MD

Nkarta, Inc.

Related
2 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Jianxiang Wang, Dr.

Institute of Hematology & Blood Diseases Hospital, China

Related
7 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic Leukemia
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05518357Phase 1PrincipalInvestigator

LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia
Completed
NCT03825718Early Phase 1PrincipalInvestigator

A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

B-cell Acute Lymphoblastic Leukemia
Completed

All 2 trials loaded